A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Clinical trial NCT02915744 · COMPLETED
Trial details
- NCT number
- NCT02915744
- Sponsor
- Nektar Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2020-07-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.